ESPR - Esperion Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $22.03. This is a potential upside of $18.73 (567.58%) from yesterday's end of day stock price of $3.3.

Esperion Therapeutics's activity chart (see below) currently has 223 price targets and 160 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.95% with an average time for these price targets to be met of 100.42 days.

Highest price target for ESPR is $16, Lowest price target is $4, average price target is $10.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 19-Sep-2025.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$16

$13.35 (503.77%)

$16

16 days ago
(19-Sep-2025)

0/7 (0%)

$13.34 (501.50%)

Buy

$4

$1.35 (50.94%)

$7

7 months 24 days ago
(11-Feb-2025)

0/3 (0%)

$2.21 (123.46%)

$3

$-0.3 (-9.09%)

2 years 6 months 19 days ago
(16-Mar-2023)

4/5 (80%)

$1.45 (93.55%)

74

Hold

$8

2 years 6 months 20 days ago
(15-Mar-2023)

0/1 (0%)

$1.84 (29.87%)

Buy

$16

2 years 6 months 20 days ago
(15-Mar-2023)

0/2 (0%)

$10.92 (214.96%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ESPR (Esperion Therapeutics) average time for price targets to be met?

On average it took 100.42 days on average for the stock forecasts to be realized with a an average price target met ratio 40.95

Which analyst has the current highest performing score on ESPR (Esperion Therapeutics) with a proven track record?

JOEL BEATTY

Which analyst has the most public recommendations on ESPR (Esperion Therapeutics)?

Joel Beatty works at BAIRD and has 11 price targets and 8 ratings on ESPR

Which analyst is the currently most bullish on ESPR (Esperion Therapeutics)?

Chris Shibutani with highest potential upside - $90.7

Which analyst is the currently most reserved on ESPR (Esperion Therapeutics)?

Jeffrey Hung with lowest potential downside - -$0.3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?